Literature DB >> 2457547

Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes.

G Essery1, M Feldmann, J R Lamb.   

Abstract

The exposure of human T-cell clones to supra-immunogenic concentrations of peptide antigen in the absence of accessory cells induces antigen-specific unresponsiveness. Using this model we have investigated the ability of cytokines to modulate the induction of, or reversal of, T-cell tolerance. Our findings demonstrate that interleukin-2 (IL-2), but not interferon-gamma (IFN-gamma) or interleukin-1 (IL-1), is able to inhibit the induction of T-cell unresponsiveness in a dose-dependent fashion. Moreover, IL-2 was able to reverse established antigen-dependent T-cell unresponsiveness. In order to determine if modulation of IL-2 receptors is able to induce or abrogate unresponsiveness, the T cells were treated with anti-Tac antibody alone or together with tolerizing concentrations of antigen. Anti-Tac antibody was neither able to induce nor inhibit the induction of tolerance. The application of this model in the manipulation of immune responses is discussed here.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457547      PMCID: PMC1385051     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

Review 2.  Regulation of HLA class II expression and its role in autoimmune disease.

Authors:  M Feldmann
Journal:  Ciba Found Symp       Date:  1987

3.  Antigen-specific T cell unresponsiveness in cloned helper T cells mediated via the CD2 or CD3/Ti receptor pathways.

Authors:  J R Lamb; E D Zanders; W Sewell; M J Crumpton; M Feldmann; M J Owen
Journal:  Eur J Immunol       Date:  1987-11       Impact factor: 5.532

4.  A human suppressor T cell clone which recognizes an autologous helper T cell clone.

Authors:  J R Lamb; M Fledmann
Journal:  Nature       Date:  1982-12-02       Impact factor: 49.962

5.  Tolerance of T-cell clones is associated with membrane antigen changes.

Authors:  E D Zanders; J R Lamb; M Feldmann; N Green; P C Beverley
Journal:  Nature       Date:  1983 Jun 16-22       Impact factor: 49.962

6.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

7.  Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones.

Authors:  J R Lamb; D D Eckels; P Lake; A H Johnson; R J Hartzman; J N Woody
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones.

Authors:  M K Jenkins; D M Pardoll; J Mizuguchi; T M Chused; R H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

9.  Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma.

Authors:  G Buchan; K Barrett; T Fujita; T Taniguchi; R Maini; M Feldmann
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

10.  Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin.

Authors:  J R Lamb; B J Skidmore; N Green; J M Chiller; M Feldmann
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

View more
  36 in total

Review 1.  The potential of peptide immunotherapy in allergy and asthma.

Authors:  F Runa Ali; A Barry Kay; Mark Larché
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

2.  Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo.

Authors:  H Belfrage; M Dohlsten; G Hedlund; T Kalland
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

3.  T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.

Authors:  L A Turka; P S Linsley; H Lin; W Brady; J M Leiden; R Q Wei; M L Gibson; X G Zheng; S Myrdal; D Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

4.  Mesenchymal stem cells differentially mediate regulatory T cells and conventional effector T cells to protect fully allogeneic islet grafts in mice.

Authors:  D M Xu; X F Yu; D Zhang; M X Zhang; J F Zhou; P H Tan; Y C Ding
Journal:  Diabetologia       Date:  2012-01-20       Impact factor: 10.122

5.  Enhancement of a delayed hypersensitivity reaction to a contact allergen, by the systemic administration of interleukin-2.

Authors:  Y Zaloom; L P Walsh; P McCulloch; G Gallagher
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

6.  A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.

Authors:  Paul E Zarek; Ching-Tai Huang; Eric R Lutz; Jeanne Kowalski; Maureen R Horton; Joel Linden; Charles G Drake; Jonathan D Powell
Journal:  Blood       Date:  2007-10-01       Impact factor: 22.113

7.  Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response.

Authors:  P McCulloch; G Gallagher; L P Walsh; Y Zaloom; J Xie
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

8.  Influenza peptide-induced self-lysis and down-regulation of cloned cytotoxic T cells.

Authors:  R M Pemberton; D C Wraith; B A Askonas
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

9.  CD4+ T-helper-cell responses in mice with low-level Candida albicans infection.

Authors:  A Mencacci; R Spaccapelo; G Del Sero; K H Enssle; A Cassone; F Bistoni; L Romani
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

10.  Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9.

Authors:  Yunchuan Ding; Danmei Xu; Gang Feng; Andrew Bushell; Ruth J Muschel; Kathryn J Wood
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.